Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 02, 2015 Filed Apr 3, 2015 20:56 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
SaleCommon Stock | 16,637 | $102.71 | $1,708,786.27 |
DisclosureSEC source: 0001127602-15-013956 · form4.xml · nonDerivative · entry 7 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,841.059 F2 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F6 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $101.75 and $103.24 per share. Read SEC document |
| April 02, 2015 Filed Apr 3, 2015 20:56 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 16,637 | $45.07 | $749,829.59 |
DisclosureSEC source: 0001127602-15-013956 · form4.xml · nonDerivative · entry 6 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,478.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2015 Filed Apr 3, 2015 20:56 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Tax withholdingCommon Stock | 3,989 | $102.71 | $409,710.19 |
DisclosureSEC source: 0001127602-15-013956 · form4.xml · nonDerivative · entry 5 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,841.059 F5 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:28 UTC |
Bisaccia LisaEVP, Chief HR Officer
|
GrantStock Option · Derivative | 34,241 | $102.26 Strike: $102.26 | $3,501,484.66 |
DisclosureSEC source: 0001127602-15-013946 · form4.xml · derivative · entry 5 Bisaccia Lisa · CIK 0001479663 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,241 Underlying: Common Stock · 34,241 shares Expires 2022-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:28 UTC |
Bisaccia LisaEVP, Chief HR Officer
|
GrantCommon Stock (restricted) | 4,889 | $102.26 | $499,949.14 |
DisclosureSEC source: 0001127602-15-013946 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,011.0004 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2018 and 50% 4/1/2020. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:32 UTC |
Sussman AndrewEVP & Pres, CVS/minuteclinic
|
GrantStock Option · Derivative | 23,968 | $102.26 Strike: $102.26 | $2,450,967.68 |
DisclosureSEC source: 0001127602-15-013950 · form4.xml · derivative · entry 5 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,968 Underlying: Common Stock · 23,968 shares Expires 2022-04-01 F4 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:32 UTC |
Sussman AndrewEVP & Pres, CVS/minuteclinic
|
GrantCommon Stock (restricted) | 3,422 | $102.26 | $349,933.72 |
DisclosureSEC source: 0001127602-15-013950 · form4.xml · nonDerivative · entry 2 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,964 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2018 and 50% 4/1/2020. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:32 UTC |
Sussman AndrewEVP & Pres, CVS/minuteclinic
|
Tax withholdingCommon Stock | 3,086 | $102.26 | $315,574.36 |
DisclosureSEC source: 0001127602-15-013950 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,211 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:22 UTC |
GOLD STEPHEN JEVP & CIO
|
GrantStock Option · Derivative | 41,089 | $102.26 Strike: $102.26 | $4,201,761.14 |
DisclosureSEC source: 0001127602-15-013940 · form4.xml · derivative · entry 5 GOLD STEPHEN J · CIK 0001252005 · EVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,089 Underlying: Common Stock · 41,089 shares Expires 2022-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:22 UTC |
GOLD STEPHEN JEVP & CIO
|
GrantCommon Stock (restricted) | 5,867 | $102.26 | $599,959.42 |
DisclosureSEC source: 0001127602-15-013940 · form4.xml · nonDerivative · entry 1 GOLD STEPHEN J · CIK 0001252005 · EVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,403 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2018 and 50% 4/1/2020. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:35 UTC |
Foulkes HelenaEVP, President-CVS/pharmacy
|
GrantStock Option · Derivative | 59,922 | $102.26 Strike: $102.26 | $6,127,623.72 |
DisclosureSEC source: 0001127602-15-013951 · form4.xml · derivative · entry 6 Foulkes Helena · CIK 0001429996 · EVP, President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,922 Underlying: Common Stock · 59,922 shares Expires 2022-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:35 UTC |
Foulkes HelenaEVP, President-CVS/pharmacy
|
GrantCommon Stock (restricted) | 8,556 | $102.26 | $874,936.56 |
DisclosureSEC source: 0001127602-15-013951 · form4.xml · nonDerivative · entry 1 Foulkes Helena · CIK 0001429996 · EVP, President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,653 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2018 and 50% 4/1/2020. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:39 UTC |
MERLO LARRY JDirector · President and CEO
|
GrantStock Option · Derivative | 273,929 | $102.26 Strike: $102.26 | $28,011,979.54 |
DisclosureSEC source: 0001127602-15-013952 · form4.xml · derivative · entry 6 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,929 Underlying: Common Stock · 273,929 shares Expires 2022-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:39 UTC |
MERLO LARRY JDirector · President and CEO
|
GrantCommon Stock (restricted) | 39,115 | $102.26 | $3,999,899.90 |
DisclosureSEC source: 0001127602-15-013952 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,095 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2018 and 50% 4/1/2020. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 21:00 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
GrantStock Option · Derivative | 23,968 | $102.26 Strike: $102.26 | $2,450,967.68 |
DisclosureSEC source: 0001127602-15-013957 · form4.xml · derivative · entry 4 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,968 Underlying: Common Stock · 23,968 shares Expires 2022-04-01 F4 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 21:00 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
GrantCommon Stock (restricted) | 3,422 | $102.26 | $349,933.72 |
DisclosureSEC source: 0001127602-15-013957 · form4.xml · nonDerivative · entry 2 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,400 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2018 and 50% 4/1/2020. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 21:00 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
Tax withholdingCommon Stock | 1,801 | $102.26 | $184,170.26 |
DisclosureSEC source: 0001127602-15-013957 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,599 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:49 UTC |
Roberts Jonathan CEVP & President, CVS/caremark
|
GrantStock Option · Derivative | 68,482 | $102.26 Strike: $102.26 | $7,002,969.32 |
DisclosureSEC source: 0001127602-15-013953 · form4.xml · derivative · entry 6 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,482 Underlying: Common Stock · 68,482 shares Expires 2022-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:49 UTC |
Roberts Jonathan CEVP & President, CVS/caremark
|
GrantCommon Stock (restricted) | 9,778 | $102.26 | $999,898.28 |
DisclosureSEC source: 0001127602-15-013953 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,753 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2018 and 50% 4/1/2020. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:53 UTC |
Denton David MEVP, CFO
|
GrantStock Option · Derivative | 59,922 | $102.26 Strike: $102.26 | $6,127,623.72 |
DisclosureSEC source: 0001127602-15-013954 · form4.xml · derivative · entry 4 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,922 Underlying: Common Stock · 59,922 shares Expires 2022-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:53 UTC |
Denton David MEVP, CFO
|
GrantCommon Stock (restricted) | 8,556 | $102.26 | $874,936.56 |
DisclosureSEC source: 0001127602-15-013954 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,351 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2018 and 50% 4/1/2020. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:56 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
GrantStock Option · Derivative | 47,937 | $102.26 Strike: $102.26 | $4,902,037.62 |
DisclosureSEC source: 0001127602-15-013956 · form4.xml · derivative · entry 9 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,937 Underlying: Common Stock · 47,937 shares Expires 2022-04-01 F8 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:56 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionStock Option · Derivative | 16,747 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-15-013956 · form4.xml · derivative · entry 8 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,747 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:56 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
GrantCommon Stock (restricted) | 6,845 | $102.26 | $699,969.70 |
DisclosureSEC source: 0001127602-15-013956 · form4.xml · nonDerivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,858 F4 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2018 and 50% 4/1/2020. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:56 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
SaleCommon Stock | 16,747 | $102.26 | $1,712,548.22 |
DisclosureSEC source: 0001127602-15-013956 · form4.xml · nonDerivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,510.059 F2 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $101.60 and $102.47 per share. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:56 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 16,747 | $34.96 | $585,475.12 |
DisclosureSEC source: 0001127602-15-013956 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,257.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:56 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Tax withholdingCommon Stock | 2,234 | $102.26 | $228,448.84 |
DisclosureSEC source: 0001127602-15-013956 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,510.059 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 21:02 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
GrantStock Option · Derivative | 27,392 | $102.26 Strike: $102.26 | $2,801,105.92 |
DisclosureSEC source: 0001127602-15-013958 · form4.xml · derivative · entry 4 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,392 Underlying: Common Stock · 27,392 shares Expires 2022-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 21:02 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
GrantCommon Stock (restricted) | 3,911 | $102.26 | $399,938.86 |
DisclosureSEC source: 0001127602-15-013958 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,872 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2018 and 50% 4/1/2020. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 21:02 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 1,029 | $102.26 | $105,225.54 |
DisclosureSEC source: 0001127602-15-013958 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,815.5077 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 21:05 UTC |
Moriarty Thomas MEVP & General Counsel
|
GrantStock Option · Derivative | 51,361 | $102.26 Strike: $102.26 | $5,252,175.86 |
DisclosureSEC source: 0001127602-15-013959 · form4.xml · derivative · entry 5 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,361 Underlying: Common Stock · 51,361 shares Expires 2022-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 21:05 UTC |
Moriarty Thomas MEVP & General Counsel
|
GrantCommon Stock (restricted) | 7,334 | $102.26 | $749,974.84 |
DisclosureSEC source: 0001127602-15-013959 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,891 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2018 and 50% 4/1/2020. Read SEC document |
| March 23, 2015 Filed Mar 24, 2015 20:12 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionStock Option · Derivative | 33,274 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-15-012425 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,274 Underlying: Common Stock · 33,274 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| March 23, 2015 Filed Mar 24, 2015 20:12 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
SaleCommon Stock | 33,274 | $104.94 | $3,491,773.56 |
DisclosureSEC source: 0001127602-15-012425 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,086.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $104.20 and $105.32 per share. Read SEC document |
| March 23, 2015 Filed Mar 24, 2015 20:12 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 33,274 | $45.07 | $1,499,659.18 |
DisclosureSEC source: 0001127602-15-012425 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,360.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2015 Filed Mar 23, 2015 20:19 UTC |
BROWN C DAVID IIDirector
|
SaleCommon Stock | 25,000 | $104.30 | $2,607,500.00 |
DisclosureSEC source: 0001127602-15-012308 · form4.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,252 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 Plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $103.52 and $104.68 per share. Read SEC document |
| March 05, 2015 Filed Mar 6, 2015 21:39 UTC |
DECOUDREAUX ALECIA ADirector
|
GrantShare Credits · Derivative | 451.4964 | $103.36 Strike: $0.00 | $46,666.67 |
DisclosureSEC source: 0001127602-15-010450 · form4.xml · derivative · entry 1 DECOUDREAUX ALECIA A · CIK 0001233354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 451.4964 Underlying: Common Stock · 451.4964 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a pro rata portion of the retainer payable for the Reporting Person's service during the 2014-2015 Board year. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| March 02, 2015 Filed Mar 3, 2015 21:56 UTC |
MERLO LARRY JDirector · President and CEO
|
GiftCommon Stock | 2,419 | $104.19 | $252,035.61 |
DisclosureSEC source: 0001127602-15-009628 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,911.7496 Read SEC document |
| March 02, 2015 Filed Mar 3, 2015 22:02 UTC |
Roberts Jonathan CEVP & President, CVS/caremark
|
GiftCommon Stock | 98 | $104.19 | $10,210.62 |
DisclosureSEC source: 0001127602-15-009639 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,034.0256 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 21:53 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
GrantCommon Stock (restricted) | 1,720 | $103.87 | $178,656.40 |
DisclosureSEC source: 0001127602-15-009622 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,107 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan and its Performance-Based Restricted Stock Unit Plan. Restrictions lapse in three equal installments, commencing February 27, 2016. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 21:53 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
GrantCommon Stock | 2,406 | $103.87 | $249,911.22 |
DisclosureSEC source: 0001127602-15-009622 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,698.5077 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 21:59 UTC |
Denton David MEVP, CFO
|
GrantCommon Stock | 18,051 | $103.87 | $1,874,957.37 |
DisclosureSEC source: 0001127602-15-009631 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,968.3964 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 21:56 UTC |
MERLO LARRY JDirector · President and CEO
|
GrantCommon Stock | 66,188 | $103.87 | $6,874,947.56 |
DisclosureSEC source: 0001127602-15-009628 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,330.7496 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:02 UTC |
Roberts Jonathan CEVP & President, CVS/caremark
|
GrantCommon Stock | 15,644 | $103.87 | $1,624,942.28 |
DisclosureSEC source: 0001127602-15-009639 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,132.0256 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:07 UTC |
Foulkes HelenaEVP, President-CVS/pharmacy
|
GrantCommon Stock | 9,627 | $103.87 | $999,956.49 |
DisclosureSEC source: 0001127602-15-009645 · form4.xml · nonDerivative · entry 1 Foulkes Helena · CIK 0001429996 · EVP, President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,775.0588 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:04 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
GrantCommon Stock | 13,839 | $103.87 | $1,437,456.93 |
DisclosureSEC source: 0001127602-15-009642 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,086.059 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:09 UTC |
Bisaccia LisaSVP, Chief HR Officer
|
GrantCommon Stock | 9,627 | $103.87 | $999,956.49 |
DisclosureSEC source: 0001127602-15-009648 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,908 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:18 UTC |
Sussman AndrewSVP & Pres, CVS/minuteclinic
|
GrantCommon Stock | 6,017 | $103.87 | $624,985.79 |
DisclosureSEC source: 0001127602-15-009657 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · SVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,861 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:16 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
GrantCommon Stock | 6,017 | $103.87 | $624,985.79 |
DisclosureSEC source: 0001127602-15-009655 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,109 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:21 UTC |
Moriarty Thomas MEVP & General Counsel
|
GrantStock Unit | 6,768 | $103.87 | $702,992.16 |
DisclosureSEC source: 0001127602-15-009663 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,768 F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.